跳转至内容
Merck
CN

D-047

Supelco

N-去甲基西酞普兰盐酸盐 盐酸盐 溶液

1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

别名:

N-去甲基西酞普兰盐酸盐 盐酸盐 溶液

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C19H19FN2O · HCl
分子量:
346.83
MDL编号:
UNSPSC代码:
41116107
NACRES:
NA.24

等级

certified reference material

质量水平

表单

liquid

特点

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

浓度

1.0 mg/mL in methanol (as free base)

技术

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

应用

clinical testing

包装形式

single component solution

储存温度

−20°C

SMILES字符串

Fc1ccc(cc1)[C@@]2(OCc3c2ccc(c3)C#N)CCCNC

InChI

1S/C19H19FN2O/c1-22-10-2-9-19(16-4-6-17(20)7-5-16)18-8-3-14(12-21)11-15(18)13-23-19/h3-8,11,22H,2,9-10,13H2,1H3/t19-/m0/s1

InChI key

PTJADDMMFYXMMG-IBGZPJMESA-N

一般描述

N-去甲基西酞普兰是SSRI抗抑郁药西酞普兰的一种活性代谢产物。西酞普兰在美国和加拿大以Celexa®的名义进行销售,可用于治疗与情绪障碍相关的重度抑郁症。

应用


  • Reference concentrations for forensic and clinical toxicology:N-Desmethylcitalopram hydrochloride is used as a reference compound in neuropharmacological and toxicological studies (Nedahl et al., 2018).

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Celexa is a registered trademark of H. Lundbeck A/S
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

警示用语:

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

靶器官

Eyes,Central nervous system

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(°F)

49.5 °F - closed cup

闪点(°C)

9.7 °C - closed cup

法规信息

危险化学品

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Francesca-Maria Raffaelli et al.
Scientific reports, 10(1), 20203-20203 (2020-11-21)
Brown adipose tissue (BAT) thermogenesis is considered a potential target for treatment of obesity and diabetes. In vitro data suggest dopamine receptor signaling as a promising approach; however, the biological relevance of dopamine receptors in the direct activation of BAT
Lili Aslostovar et al.
Cell reports. Medicine, 2(2), 100202-100202 (2021-03-06)
The aberrant expression of dopamine receptors (DRDs) in acute myeloid leukemia (AML) cells has encouraged the repurposing of DRD antagonists such as thioridazine (TDZ) as anti-leukemic agents. Here, we access patient cells from a Phase I dose escalation trial to

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门